“…While in healthy cells, aneuploidy causes a strong anti-proliferative response as a result of gene dosage imbalances (Santaguida et al, 2015) this response can be overcome in cancer cells, allowing the increased frequency of errors to promote aneuploid karyotype evolution and acceleration of tumor formation (Duijf & Benezra, 2013; van Jaarsveld & Kops, 2016). These ideas have emerged from extensive studies of aneuploidy in different systems including cell lines (Cimini et al, 2001; Thompson & Compton, 2008, 2011a), organoids (Bolhaqueiro et al, 2019; Drost & Clevers, 2018; Narkar et al, 2021), animal models (Bolton et al, 2016; Sheppard et al, 2012; Shoshani et al, 2021; Trakala et al, 2021), as well as theoretically (Araujo et al, 2013; Desper et al, 2005; Elizalde et al, 2018; Gusev et al, 2000, 2001; Laughney et al, 2015; Lynch et al, 2021). Yet, how the interplay between chromosome missegregation, cell proliferation and other processes drives long-term karyotype evolution is poorly understood.…”